PharmaBel s.r.o.

Active
IČO 50412060limited liability company (s.r.o.)Founded 2016Spišské Vlachy

Key figures

973 857 €+8,3%
Revenue 2024
+10,8%
Average annual growth 2021–2024
0250 k500 k750 k1 m2021202220232024

Key figures

2024

Dividends

calculated
2024

Distributed as dividends 56 697 € (100 % of distributable profit).

In addition, equity decreased by 5 000 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.

History
dividends other decrease in equity
202456 697 €+5 000 € other
202311 123 €
20220 €

Summary: PharmaBel s.r.o.

What kind of company is it?

PharmaBel s.r.o. (IČO 50412060) is a limited liability company (s.r.o.). The company was incorporated in 2016 and has existed for 10 years. Registered office according to the register: Spišské Vlachy. Main activity according to the Statistical Office: ostatný nešpecializovaný maloobchod (SK NACE 4712). Size category by number of employees: 5–9 employees.

Who runs the company and who owns it?

The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2024 was 973 857 €, up 8,3 % on the previous year (899 080 €). From 2021 to 2024, revenue grew by an average of 10,8 % per year. This is the highest revenue in the reported years (2021–2024). Net profit for 2024 was 23 968 € (2,5 % of revenue). The company was profitable in all 4 reported years. Personnel costs for 2024 were 103 725 €. At the end of 2024 the company had total assets of 59 324 € and equity of 23 968 € (equity ratio 40,4 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2021–2024
2021202220232024
Revenue (net turnover)715 951838 761899 080973 857
Profit for the reporting year13 82311 12215 97923 968
Retained earnings of previous periods26 89540 71940 7180
Total assets457 831171 891269 40559 324
Total liabilities412 113115 050196 63735 356
Total equity45 71856 84161 69723 968
Calculated dividends—011 12356 697

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Jana Šefčíková is the only person registered with this company; the register shows no other connections.

Documents in the Register of Financial Statements4

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4712)
PharmaBel s.r.o. (IČO 50412060) – revenue 974K € | icoprofil.sk